FN1 and breast cancer: Indeed, Tabariès et al. demonstrated that the use of neutralizing antibodies targeting α5β1 or α2β1 complexes can efficiently inhibit the binding of claudin 2-overexpressing BC cells to FN and collagen IV, consequently reducing the ability of BC cells to metastasize to the liver [258].